Literature DB >> 27558930

Monitoring and evaluation of out-of-office blood pressure during pregnancy.

Hirohito Metoki1,2,3, Noriyuki Iwama2,4, Mami Ishikuro3, Michihiro Satoh1, Takahisa Murakami1, Hidekazu Nishigori2.   

Abstract

Blood pressure (BP) is important to measure during pregnancy because it provides the basis for classifying hypertension, which has several etiologies. Similarly, monitoring home and ambulatory BP can provide useful information outside a medical setting for adults who are not pregnant. Office BP is higher during early pregnancy in primiparous women than in multiparous women, whereas out-of-office BP does not differ between them. White-coat hypertension might be benign compared with hypertension determined from ambulatory BP values that might be associated with a high risk for preeclampsia. Although reference values have been proposed on the basis of the distribution of BP among normotensive pregnant women, prognosis-based reference values are also required.

Entities:  

Mesh:

Year:  2016        PMID: 27558930     DOI: 10.1038/hr.2016.112

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  32 in total

1.  Prognostic value of ambulatory blood pressure monitoring in pregnancy.

Authors:  Ramón C Hermida; Diana E Ayala
Journal:  J Hypertens       Date:  2010-05       Impact factor: 4.844

2.  Describing and interpreting 24-hour blood pressure patterns in physiologic pregnancy.

Authors:  P Cugini; L Di Palma; P Battisti; G Leone; A Pachí; R Paesano; C Masella; G Stirati; A Pierucci; A R Rocca
Journal:  Am J Obstet Gynecol       Date:  1992-01       Impact factor: 8.661

3.  Daily serial hemodynamic data during pregnancy and seasonal variation: the BOSHI study.

Authors:  Hirohito Metoki; Takayoshi Ohkubo; Taku Obara; Konomi Akutsu; Mami Yamamoto; Mami Ishikuro; Kasumi Sakurai; Noriyuki Iwama; Mikiko Katagiri; Junichi Sugawara; Takuo Hirose; Michihiro Sato; Masahiro Kikuya; Katsuyo Yagihashi; Yoichi Matsubara; Nobuo Yaegashi; Shigeru Mori; Masakuni Suzuki; Yutaka Imai
Journal:  Clin Exp Hypertens       Date:  2012-05-11       Impact factor: 1.749

4.  Effect of age, parity, and race on the incidence of pregnancy associated hypertension and eclampsia in the United States.

Authors:  Robert A Gold; Kellyanne R Gold; Mark F Schilling; Tamara Modilevsky
Journal:  Pregnancy Hypertens       Date:  2013-10-30       Impact factor: 2.899

Review 5.  Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy.

Authors:  Laura A Magee; Anouk Pels; Michael Helewa; Evelyne Rey; Peter von Dadelszen
Journal:  Pregnancy Hypertens       Date:  2014-02-25       Impact factor: 2.899

6.  Relationship between maternal gestational hypertension and home blood pressure in 7-year-old children and their mothers: Tohoku Study of Child Development.

Authors:  Miki Hosaka; Kei Asayama; Jan A Staessen; Nozomi Tatsuta; Michihiro Satoh; Masahiro Kikuya; Takayoshi Ohkubo; Hiroshi Satoh; Yutaka Imai; Kunihiko Nakai
Journal:  Hypertens Res       Date:  2015-05-14       Impact factor: 3.872

7.  The SOMANZ Guidelines for the Management of Hypertensive Disorders of Pregnancy 2014.

Authors:  Sandra A Lowe; Lucy Bowyer; Karin Lust; Lawrence P McMahon; Mark R Morton; Robyn A North; Michael J Paech; Joanne M Said
Journal:  Aust N Z J Obstet Gynaecol       Date:  2014-10-11       Impact factor: 2.100

8.  Ambulatory BP monitoring and clinic BP in predicting small-for-gestational-age infants during pregnancy.

Authors:  K Eguchi; T Ohmaru; A Ohkuchi; C Hirashima; K Takahashi; H Suzuki; K Kario; S Matsubara; Mitsuaki Suzuki
Journal:  J Hum Hypertens       Date:  2015-03-19       Impact factor: 3.012

9.  The risk factors for labor onset hypertension.

Authors:  Yasumasa Ohno; Mikio Terauchi; Koji Tamakoshi; Arihiro Shiozaki; Shigeru Saito
Journal:  Hypertens Res       Date:  2015-10-22       Impact factor: 3.872

10.  Preconception Cardiovascular Risk Factor Differences Between Gestational Hypertension and Preeclampsia: Cohort Norway Study.

Authors:  Grace M Egeland; Kari Klungsøyr; Nina Øyen; Grethe S Tell; Øyvind Næss; Rolv Skjærven
Journal:  Hypertension       Date:  2016-04-25       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.